urotensin-II


SMILES None
InChIKey None
Sequence QHGTAPECFWKYCI

Chemical properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Drug properties

Molecular type Peptide
Endogenous/Surrogate Endogenous
Approved drug No

Database connections


Bioactivities

Receptor Activity Source
GTP Uniprot Species Family Class Type Min Avg Max Database
LPA2 LPAR2 Human Lysophospholipid (LPA) A pKi 5.25 5.25 5.25 Guide to Pharmacology
LPA3 LPAR3 Human Lysophospholipid (LPA) A pKi 6.44 6.44 6.44 Guide to Pharmacology
LPA3 LPAR3 Human Lysophospholipid (LPA) A pKi 6.83 6.83 6.83 ChEMBL
LPA1 LPAR1 Human Lysophospholipid (LPA) A pKi 6.37 6.37 6.37 ChEMBL
Receptor Activity Source
GTP Uniprot Species Family Class Type Min Avg Max Database
LPA1 LPAR1 Mouse Lysophospholipid (LPA) A pIC50 6.6 6.75 6.9 Guide to Pharmacology
LPA2 LPAR2 Human Lysophospholipid (LPA) A pIC50 5.92 5.92 5.92 ChEMBL
LPA3 LPAR3 Human Lysophospholipid (LPA) A pIC50 5.8 6.16 6.52 ChEMBL
LPA1 LPAR1 Human Lysophospholipid (LPA) A pIC50 6.1 6.53 7.34 ChEMBL
LPA1 LPAR1 Rat Lysophospholipid (LPA) A pIC50 6.8 6.8 6.8 ChEMBL